Stroke Rehabilitation Market, By Treatment Type (Devices and Therapy), By Product Type, By Stroke Type, By End-user Verticals, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4345
|
Published Date
October 2025
|
Pages
260
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Stroke Rehabilitation Market size was valued at US$ 289.39 Million in 2024, expanding at a CAGR of 11.60% from 2025 to 2032.
Rehabilitation is a crucial service that supports patients in recovering from illness or injury and helps them return to their normal daily activities. In the case of stroke rehabilitation, the goal is to restore independence by improving physical, cognitive, and emotional functions—such as movement, speech, strength, and the ability to perform everyday tasks. The specific treatment plan depends on the area of the brain affected by the stroke and the severity of the damage.
Stroke rehabilitation incorporates a range of therapeutic approaches, including motor skills exercises, mobility training, and psychological assessment and therapy. These services are delivered across various care settings, such as inpatient rehabilitation centers, outpatient clinics, skilled nursing facilities, and home-based rehabilitation programs, depending on the patient\'s condition and recovery needs.
Globally, governments are increasingly recognizing the importance of rehabilitation services. According to the World Health Organization (WHO), approximately one in four people worldwide will experience a stroke in their lifetime, highlighting the urgent need for accessible rehabilitation. Several countries have launched national programs to improve stroke rehabilitation infrastructure—for example, the U.S. government’s National Stroke Strategy and the European Union’s commitment to enhancing rehabilitation services through the European Stroke Action Plan 2018-2030. These initiatives aim to improve patient outcomes, reduce long-term disability, and promote reintegration into society.
Stroke Rehabilitation Market- Market Dynamics
Rising Prevalence of Chronic Diseases Drives Growth in the Stroke Rehabilitation Market
The rising prevalence of chronic diseases is expected to significantly boost the stroke rehabilitation market. Chronic conditions, which persist for a year or longer and often limit daily activities, require continuous medical care and support. Stroke rehabilitation plays a vital role in assisting patients affected by chronic illnesses—such as cardiovascular disease—by offering targeted therapies and assistive devices tailored to their specific needs. For example, the American College of Cardiology forecasts a substantial increase in cardiovascular disease cases in the United States, including a corresponding rise in stroke incidents. This growing burden of chronic diseases underscores the urgent need for effective stroke rehabilitation services, driving market growth through increased demand for therapies and technologies that enhance patient recovery and overall quality of life.
Globally, governments are prioritizing stroke rehabilitation as part of their healthcare strategies. According to the World Health Organization (WHO), chronic diseases account for approximately 71% of all deaths worldwide, with stroke being a leading cause of long-term disability. Many countries have implemented national action plans to improve rehabilitation services—for instance, the U.S. government’s National Stroke Strategy and the European Union’s Stroke Action Plan 2018-2030, which aim to enhance access to quality rehabilitation and reduce disability. These initiatives are fueling market growth by increasing the demand for advanced therapies and assistive devices that improve patient outcomes and quality of life.
Stroke Rehabilitation Market- Segmentation Analysis:
The Global Stroke Rehabilitation Market is segmented on the basis of Treatment Type, Product Type, Stroke Type, End-user Verticals, and Region.
The stroke rehabilitation market is segmented into three primary categories based on stroke type: Ischemic Stroke, Hemorrhagic Stroke, and Transient Ischemic Attack (TIA). Among these, the hemorrhagic stroke segment is projected to witness substantial growth during the forecast period. Hemorrhagic stroke occurs when a blood vessel in the brain ruptures, leading to bleeding within or around the brain tissue. The rising global incidence of hemorrhagic strokes, driven by factors such as hypertension and aging populations, has intensified the demand for specialized rehabilitation services. According to the Centers for Disease Control and Prevention (CDC), hemorrhagic strokes account for approximately 13% of all strokes but are responsible for a disproportionately high rate of stroke-related deaths and disabilities. While rehabilitation cannot reverse the initial brain damage caused by hemorrhage, it plays a critical role in maximizing functional recovery and improving quality of life. Studies suggest that patients recovering from hemorrhagic strokes often respond better to rehabilitation compared to ischemic stroke survivors, prompting ongoing research and the development of innovative therapeutic approaches to enhance recovery outcomes.
The market is further divided based on end-user verticals into Hospitals, Ambulatory Surgical Centers, Long-Term Treatment Centers, Specialty Clinics, Home Care Settings, Rehabilitation Centers, and Other End-User Verticals. Among these, hospitals are expected to dominate the stroke rehabilitation market by 2025. Hospitals offer comprehensive rehabilitation services due to their access to advanced medical equipment, multidisciplinary healthcare teams, and substantial capital investments. Moreover, hospitals adhere to stringent regulatory and clinical standards, ensuring high-quality patient care. The prominence of hospitals in this sector is also bolstered by their active participation in clinical trials focused on stroke rehabilitation therapies. As of January 2025, the clinicaltrials.gov database lists over 416 active clinical trials related to stroke rehabilitation interventions globally, highlighting the continuous advancement and innovation in this field. Government initiatives and funding programs aimed at improving stroke recovery and reducing long-term disability are further accelerating hospital-based rehabilitation services.
Stroke Rehabilitation Market- Geographical Insights
North America is projected to hold the largest share of the stroke rehabilitation market in 2025. This growth is driven by the increasing prevalence of stroke, widespread adoption of advanced rehabilitation technologies, and a rapidly expanding geriatric population. Currently, the United States has approximately 62 million individuals aged 65 and older, representing 18% of the total population. This demographic is expected to rise to 23% by 2054, further intensifying the demand for stroke rehabilitation services. In Canada, an estimated one million people have experienced a stroke, adding to the region’s rehabilitation needs. Strong investments from both government bodies and private organizations continue to support the development and accessibility of stroke rehabilitation across North America.
Meanwhile, the Asia-Pacific region is anticipated to experience the fastest growth in the stroke rehabilitation market during the forecast period. This surge is fueled by rising stroke incidence rates, supportive government initiatives, and increasing financial investments in healthcare infrastructure. Growing awareness about stroke rehabilitation and rising disposable incomes are also contributing factors. Countries such as China, India, and Japan are at the forefront of promoting stroke rehabilitation services in the region, positioning Asia-Pacific as a rapidly expanding market.
Stroke Rehabilitation Market- Competitive Landscape:
The stroke rehabilitation market features a diverse and competitive landscape, encompassing large, well-established medical device manufacturers, specialized rehabilitation centers, and innovative technology startups. Key players such as Penumbra, Inc. (REAL System), Shanghai Siyi Intelligent Technology Co., Ltd., DJO Global, and Saebo Inc. offer a broad portfolio of rehabilitation solutions, including assistive devices, therapeutic equipment, and software platforms. Competition in the market is driven by factors such as product innovation, demonstrated clinical outcomes, and competitive pricing strategies. Additionally, rehabilitation centers and hospitals play a critical role by providing comprehensive care and tailored therapy services to patients.
Recent Developments:
- In August 2024, AmLife International marked its tenth anniversary by launching AmHope, a dedicated rehabilitation and regenerative center. The company invested RM 1.4 million to establish AmHope, which focuses on supporting seniors in recovering from stroke and other physical health challenges, reflecting its commitment to advancing rehabilitation services and improving patient quality of life.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL STROKE REHABILITATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Penumbra, Inc. (REAL System)
- Shanghai Siyi Intelligent Technology Co., Ltd.
- DJO Global.
- Saebo Inc
- Shenzhen XFT Medical
- Soterix Medical Inc.
- Restorative Therapies
- Zynex Medical, Inc
- MYOLYN
- ACP - Accelerated Care Plus
- Neurosoft
- BIONIK Inc
- EB Neuro S.p.A
- Motorika Medical
- Ottobock
- Guangzhou Longest Science & Technology Co., Ltd.
- Roceso Technologies Pte Ltd
- Brain Stimulation AB.
- Others
GLOBAL STROKE REHABILITATION MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2019 - 2032
- Devices
- Therapy
GLOBAL STROKE REHABILITATION MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Electrical Stimulators
- Table Top
- Wearable
- Robotic Stimulators
- Wireless Stimulators
- Non-Invasive Stimulators
- Cognitive Stimulators
- Other Product Types
GLOBAL STROKE REHABILITATION MARKET, BY STROKE TYPE- MARKET ANALYSIS, 2019 - 2032
- Ischemic Stroke
- Transient Ischemic Attack
- Hemorrhagic Stroke
GLOBAL STROKE REHABILITATION MARKET, BY END-USER VERTICALS- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Ambulatory Surgical Centers
- Long Term Treatment Centers
- Specialty Clinics
- Home Care Settings
- Rehabilitation Centers
- Other End User Verticals
GLOBAL STROKE REHABILITATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Stroke Rehabilitation Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Stroke Rehabilitation Market Snippet by Treatment Type
2.1.2. Stroke Rehabilitation Market Snippet by Product Type
2.1.3. Stroke Rehabilitation Market Snippet by Stroke Type
2.1.4. Stroke Rehabilitation Market Snippet by End-user Verticals
2.1.5. Stroke Rehabilitation Market Snippet by Country
2.1.6. Stroke Rehabilitation Market Snippet by Region
2.2. Competitive Insights
3. Stroke Rehabilitation Key Market Trends
3.1. Stroke Rehabilitation Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Stroke Rehabilitation Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Stroke Rehabilitation Market Opportunities
3.4. Stroke Rehabilitation Market Future Trends
4. Stroke Rehabilitation Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Stroke Rehabilitation Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Stroke Rehabilitation Market Landscape
6.1. Stroke Rehabilitation Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Stroke Rehabilitation Market – By Treatment Type
7.1. Overview
7.1.1. Segment Share Analysis, By Treatment Type, 2024 & 2032 (%)
7.1.2. Devices
7.1.3. Therapy
8. Stroke Rehabilitation Market – By Product Type
8.1. Overview
8.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
8.1.2. Electrical Stimulators
8.1.2.1. Table Top
8.1.2.2. Wearable
8.1.3. Robotic Stimulators
8.1.4. Wireless Stimulators
8.1.5. Non-Invasive Stimulators
8.1.6. Cognitive Stimulators
8.1.7. Other Product Types
9. Stroke Rehabilitation Market – By Stroke Type
9.1. Overview
9.1.1. Segment Share Analysis, By Stroke Type, 2024 & 2032 (%)
9.1.2. Ischemic Stroke
9.1.3. Transient Ischemic Attack
9.1.4. Hemorrhagic Stroke
10. Stroke Rehabilitation Market – By End-user Verticals
10.1. Overview
10.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
10.1.2. Hospitals
10.1.3. Ambulatory Surgical Centers
10.1.4. Long Term Treatment Centers
10.1.5. Specialty Clinics
10.1.6. Home Care Settings
10.1.7. Rehabilitation Centers
10.1.8. Other End User Verticals
11. Stroke Rehabilitation Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Stroke Rehabilitation Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Stroke Rehabilitation Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Stroke Rehabilitation Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Stroke Rehabilitation Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Stroke Rehabilitation Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Stroke Rehabilitation Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Penumbra, Inc. (REAL System)
12.2.2. Shanghai Siyi Intelligent Technology Co., Ltd.
12.2.3. DJO Global.
12.2.4. Saebo Inc
12.2.5. Shenzhen XFT Medical
12.2.6. Soterix Medical Inc.
12.2.7. Restorative Therapies
12.2.8. Zynex Medical, Inc
12.2.9. MYOLYN
12.2.10. ACP - Accelerated Care Plus
12.2.11. Neurosoft
12.2.12. BIONIK Inc
12.2.13. EB Neuro S.p.A
12.2.14. Motorika Medical
12.2.15. Ottobock
12.2.16. Guangzhou Longest Science & Technology Co., Ltd.
12.2.17. Roceso Technologies Pte Ltd
12.2.18. Brain Stimulation AB.
12.2.19. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
